Search results
17 gru 2020 · This update provides the rationale for the change in gonorrhea treatment recommendations to a higher dose (500 mg) of ceftriaxone and removal of azithromycin from the recommended regimen.
11 lip 2024 · In light of CDC’s recent changes to its gonorrhea treatment recommendations, can EPT be used for gonorrhea? Under current guidelines every effort should be made to ensure that a patient’s sex partners are evaluated and treated with the recommended regimen (a single dose of ceftriaxone 500 mg IM).
22 lip 2021 · Pages in this Section. Gonococcal Infections Among Adolescents and Adults. Gonococcal Infections Among Neonates. Gonococcal Infections Among Infants and Children. Next. Last Reviewed: July 22, 2021. Source: Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention.
18 gru 2020 · This report, which updates previous guidelines (5), recommends a single 500 mg IM dose of ceftriaxone for treatment of uncomplicated urogenital, anorectal, and pharyngeal gonorrhea. If chlamydial infection has not been excluded, concurrent treatment with doxycycline (100 mg orally twice a day for 7 days) is recommended.
13 kwi 2022 · Summary: The 2021 CDC STI Treatment Guidelines now recommend 500mg ceftriaxone intramuscularly once for the treatment of uncomplicated gonorrhea at all anatomic sites. If coinfection with chlamydia has not been excluded, cotreatment with doxycycline 100mg twice daily for 7 days should be added.
18 gru 2020 · Abstract. Sexually transmitted infections (STIs) caused by the bacteria Neisseria gonorrhoeae (gonococcal infections) have increased 63% since 2014 and are a cause of sequelae including pelvic inflammatory disease, ectopic pregnancy, and infertility and can facilitate transmission of human immunodeficiency virus (HIV) (1,2).
Previously, the CDC recommended a single 250-mg intramuscular dose of ceftriaxone and a single 1-g oral dose of azithromycin to treat uncomplicated gonorrhea as well as possible coinfection with Chlamydia trachomatis. However, review by CDC staff and other experts during 2018 and 2019 raised concerns about increasing drug resistance.
